Procarta Biosystems
Procarta Biosystems develops antibacterials through an adaptable DNA-based platform to counter the rise of drug-resistant bacterial strains.
Procarta Biosystems has raised €1.5M across 1 funding round from 1 investor, most recently a round in Jan 2019. Based in Norwich, UK; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.5M
€1,500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2019-01
latest 2019-01
Funding by year
EUR raised per yearProcarta Biosystems — funding by year — interactive chart.
Data table
| Procarta Biosystems — funding by year | |
|---|---|
| 2018 | €1.5M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Other | €1.5M | Repair Impact Fund | View deal → |